To advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP)), the foundation established the MDS Research Fund (MDSRF). This fund continues the work that Joseph Dresner initiated with his seminal gift to establish the Joseph Dresner Family Clinic for Hematologic Malignancies & Stem Cell Transplantation at the Karmanos Cancer Institute. The fund will expand the foundation’s investments in support of cutting-edge MDS research and related programs that will lead to the future standards of care and ultimately cure.
Purpose and Focus
The fund will facilitate the advancement of innovative basic science, translational or clinical research.
Who is Eligible
The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders. The foundation will accept proposals of two types:
- Early Career Awards: Eligible investigators who are less than 5 years from completion of fellowship training or post-doctoral program at the time of award and/or have not previously been awarded an RO1 grant or its equivalent.
- Established Investigator Awards: Eligible investigators who are 5 or more years from completion of fellowship training or post-doctoral program, or applicants who have previously received an Early Career Award from the foundation or an RO1 grant or its equivalent.
After reviewing the application guidelines, we encourage you to contact us to determine potential fit before submitting a Letter of Inquiry.
A Letter of Inquiry can be submitted at any time. We will typically notify you within four to six weeks if we are able to invite a Full Proposal.